You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cyclin-dependent Kinase 4

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cyclin-dependent Kinase 4/6 Inhibitors on Body Composition in

Recruiting
  • Breast Cancer
  • CT scans
  • DEXA scan
  • Bronx, New York
    Montefiore Medical Center
Jan 6, 2023

Extensive-stage Small-cell Lung Cancer Trial (Trilaciclib, Placebo, Topotecan)

Not yet recruiting
  • Extensive-stage Small-cell Lung Cancer
  • (no location specified)
May 22, 2023

Cyclin-dependent Kinase Inhibitor 2A on Labor-related Signals

Not yet recruiting
  • Preterm Labor
    • (no location specified)
    May 9, 2023

    Neurofibromatosis 1 Trial run by the National Cancer Institute (NCI) (Abemaciclib)

    Recruiting
    • Neurofibromatosis 1
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Advanced Breast Cancer, Treatment-Refractory Solid Tumors, Retinoblastoma Deficiency Trial in Providence (Palbociclib Oral

    Not yet recruiting
    • Advanced Breast Cancer
    • +6 more
    • Providence, Rhode Island
      Lifespan Cancer Institute
    Feb 1, 2023

    Skin Health and Quality of Life in Patients Receiving

    Not yet recruiting
    • Lung Cancer
    • +7 more
    • EQ-5D-5L questionnaire
    • +2 more
    • Roma, Italy
      Roberto Iacovelli
    May 17, 2023

    Metastatic Breast Cancer Trial in Spain (Pembrolizumab, Paclitaxel)

    Active, not recruiting
    • Metastatic Breast Cancer
    • Hospitalet de Llobregat, Barcelona, Spain
    • +6 more
    Jan 23, 2023

    Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer Trial in Miami (AI+CDK4/6i, SERD+CDK4/6i, mTOR inhibitor +

    Not yet recruiting
    • Breast Cancer
    • +3 more
    • Miami, Florida
      University of Miami
    Apr 12, 2023

    Advanced Breast Cancer Trial in China (Palbociclib, Letrozole)

    Active, not recruiting
    Has Results
    • Advanced Breast Cancer
    • Beijing, Beijing, China
    • +6 more
    Jun 23, 2022

    Personalised Disease Monitoring in Metastatic Breast Cancer

    Recruiting
    • Breast Cancer Metastatic
    • Estrogen Receptor-positive Breast Cancer
      • Gothenburg, Sweden
      • +6 more
      Dec 7, 2022

      Patients With Cyclin-dependent Kinase-like 5 Deficiency Disorder

      Recruiting
      • Cyclin-Dependent Kinase-Like 5 Deficiency Disorder
      • No intervention; observational
      • Norcross, Georgia
        Center for Rare Neurological Diseases
      Oct 20, 2022

      Toxicity Data in Advanced Breast Cancer Treated With CDK

      Completed
      • Breast Cancer Stage IV
        • Athens, Greece
          Hellenic Oncology Cooperative Group
        Feb 11, 2021

        Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8, Metastatic Breast Carcinoma, Metastatic Malignant

        Withdrawn
        • Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8
        • +3 more
        • (no location specified)
        Oct 13, 2021

        Metastatic Breast Cancer, Advanced Breast Cancer, Quality of Life Trial in Worldwide (CDK 4/6 inhibitors, Endocrine therapy)

        Not yet recruiting
        • Metastatic Breast Cancer
        • +4 more
        • CDK 4/6 inhibitors
        • Endocrine therapy
        • Helsinki, Finland
        • +11 more
        Sep 19, 2023

        Metastatic Breast Cancer, Breast Carcinoma Trial in United States (LEE-011, Fulvestrant, Placebo)

        Active, not recruiting
        • Metastatic Breast Cancer
        • Breast Carcinoma
        • Birmingham, Alabama
        • +12 more
        Feb 17, 2022

        Cancer Trial in Boston (CYC065)

        Active, not recruiting
        • Cancer
        • Boston, Massachusetts
          Dana-Farber Cancer Institute
        Apr 22, 2022

        Breast Cancer Trial in Baltimore (Endocrine Therapy and a CDK 4/6 inhibitor)

        Recruiting
        • Breast Cancer
        • Endocrine Therapy and a CDK 4/6 inhibitor
        • Baltimore, Maryland
          Johns Hopkins University
        Jul 18, 2022

        Breast Cancer Stage IV Trial in Mansoura (comparing both arms as regard the objective response rate, toxicity profile, quality

        Recruiting
        • Breast Cancer Stage IV
        • comparing both arms as regard the objective response rate, toxicity profile, quality of life, progression free survival
        • Mansoura, Dakahlia, Egypt
          Oncology center mansoura university
        Jan 1, 2023

        Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma Trial in Los Angeles

        Recruiting
        • Recurrent Endometrial Carcinoma
        • +3 more
        • Los Angeles, California
          UCLA / Jonsson Comprehensive Cancer Center
        Oct 28, 2021

        Chondrosarcoma, Osteosarcoma, Soft Tissue Sarcoma Trial in United States (Abemaciclib)

        Recruiting
        • Chondrosarcoma
        • +2 more
        • Jacksonville, Florida
        • +3 more
        Apr 4, 2022

        Oligodendroglioma, Oligoastrocytoma Trial in Spain (Palbociclib)

        Completed
        • Oligodendroglioma
        • Oligoastrocytoma
        • Las Palmas de Gran Canaria, Las Palmas, Spain
        • +10 more
        Apr 1, 2020

        Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Solid Tumor Trial in United States (CDK Inhibitor

        Active, not recruiting
        • Advanced Malignant Solid Neoplasm
        • +2 more
        • CDK Inhibitor AT7519
        • +3 more
        • Washington, District of Columbia
        • +5 more
        Oct 18, 2022

        Triple Negative Breast Tumors Trial in Poland (Palbociclib, Paclitaxel, Carboplatin)

        Not yet recruiting
        • Triple Negative Breast Neoplasms
        • Wrocław, Dolnośląskie, Poland
        • +5 more
        Oct 4, 2021

        CDKL5 Disorder Trial (Ganaxolone)

        Available
        • CDKL5 Disorder
        • (no location specified)
        Apr 1, 2022

        Breast Cancer Trial (Chidamide+ Fulvestrant)

        Not yet recruiting
        • Breast Cancer
        • Chidamide+ Fulvestrant
        • (no location specified)
        Jan 13, 2022